Regulations.gov document
E20 Adaptive Designs for Clinical Trials - Draft Guidance for Industry
Other · FDA-2025-D-3023 · posted Sep 30, 2025
Key facts
| Document ID | FDA-2025-D-3023-0002 |
|---|---|
| Title | E20 Adaptive Designs for Clinical Trials - Draft Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2025-D-3023 |
| Posted | Sep 30, 2025 |
| Comment period opens | Sep 30, 2025 |
| Comments due | Dec 2, 2025 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: